Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Other Working Capital Changes came in at -$106000.0 in Q1 2026, down 9.28% YoY from -$116840.9 in Q1 2025, and down 3.92% on a QoQ basis from -$102000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 8 years of Other Working Capital Changes data on file, last reported at -$106000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 9.28% year-over-year to -$106000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$410000.0 (down 8.75% YoY) and the FY2025 annual result came in at -$401000.0, down 8.67% from the prior year.
- Other Working Capital Changes fell to -$106000.0 in Q1 2026, from -$102000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $9.8 million in Q2 2024 to a low of -$7.0 million in Q1 2025.
- A 5-year average of $754764.7 and a median of $563000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 0.0% in 2022, down 107.75% in 2022.
- Tracing CPRX's Other Working Capital Changes over 5 years: stood at -$78000.0 in 2022, then slipped by 10.26% to -$86000.0 in 2023, then retreated by 9.3% to -$94000.0 in 2024, then slipped by 8.51% to -$102000.0 in 2025, then fell by 3.92% to -$106000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$106000.0 (Q1 2026), -$102000.0 (Q4 2025), and -$102000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Mar 31, 2026 | -2.45 Mn |
| Dec 31, 2025 | -6.91 Mn |
| Dec 31, 2025 | -6.91 Mn |
| Dec 31, 2025 | -6.91 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Sep 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Mar 31, 2025 | -7.02 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Dec 31, 2024 | 2.66 Mn |
| Sep 30, 2024 | -5.17 Mn |
| Sep 30, 2024 | -5.17 Mn |